Organo First Quarter 2026 Earnings: Revenues Beat Expectations, EPS Lags

Organo (TSE:6368) First Quarter 2026 Results

Key Financial Results

• Revenue: JP¥38.1b (up 21% from 1Q 2025).
• Net income: JP¥3.64b (up 36% from 1Q 2025).
• Profit margin: 9.6% (up from 8.5% in 1Q 2025). The increase in margin was driven by higher revenue.
• EPS: JP¥79.23 (up from JP¥58.25 in 1Q 2025).

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Organo Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 10%. Earnings per share (EPS) missed analyst estimates by 14%.

Looking ahead, revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Machinery industry in Japan.

Performance of the Japanese Machinery industry.

The company's shares are up 15% from a week ago.

Risk Analysis

It is worth noting though that we have found 1 warning sign for Organo that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.